Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
A U.S. military contractor has agreed to an $11.2 million settlement with the U.S. Department of Justice to resolve allegations it lied about properly securing sensitive patient data tied to the Tricare program.
In an SEC filing, the insurer argues that requests by investors for more reporting on claims denials may already be satisfied through its regulatory compliance processes.
According to a report from Bloomberg Law, UnitedHealth has hired a prestigious defamation law firm to police what it deems as misinformation posted online.
U.S. House Rep. Greg Murphy, MD (R-NC), scolded the CEO of NYU Langone for buying the expensive ad, requesting in an open letter that the hospital release financial data related to its cost.
New data from the Private Equity Stakeholder Project reveals that, while 11% of all-sector bankruptcies were filed by organizations with a history of ownership by investment firms, that number rises to 21% for healthcare.
If 25% tariffs go into effect, it could have a big impact on the cost of medical imaging and radiotherapy systems, with many manufacturing facilities in Mexico.